We are live on ! Find out more
PPBT

Purple Biotech
PPBT

14 hedge funds and large institutions have $240K invested in Purple Biotech in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,530% more call options, than puts

Call options by funds: $326K | Put options by funds: $20K

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

40% more funds holding

Funds holding: 10 → 14 (+4)

7% more capital invested

Capital invested by funds: $224K → $240K (+$15.6K)

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
14
Holders Change
+4
Holders Change %
+40%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
2
Closed
2
Calls
$326K
Puts
$20K
Net Calls
+$306K
Net Calls Change
-$96K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$87.9K
2
Fisher Asset Management
Fisher Asset Management
Washington
+$61.8K
3
GSC
Ground Swell Capital
South Carolina
+$28.4K
4
Morgan Stanley
Morgan Stanley
New York
+$10.7K
5
BAM
Belpointe Asset Management
Nevada
+$4.99K

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$38.4K
2
WTB
Washington Trust Bank
Washington
-$33K
3
Simplex Trading
Simplex Trading
Illinois
-$11.5K
4
UBS Group
UBS Group
Switzerland
-$4.61K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$63.3K +$87.9K +229 New
Fisher Asset Management
2
Fisher Asset Management
Washington
$44K +$61.8K +161 New
Morgan Stanley
3
Morgan Stanley
New York
$30.2K +$10.7K +28 +35%
GSC
4
Ground Swell Capital
South Carolina
$20.3K +$28.4K +74 New
VVP
5
Venture Visionary Partners
Ohio
$18K – – –
WAOI
6
Wealth Advisors of Iowa
Iowa
$17.3K +$2.3K +6 +11%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$17K – – –
UBS Group
8
UBS Group
Switzerland
$11.4K -$4.61K -12 -23%
Group One Trading
9
Group One Trading
Illinois
$5.8K -$38.4K -100 -83%
FA
10
Fiduciary Alliance
South Carolina
$4.49K +$6.14K +16 New
BAM
11
Belpointe Asset Management
Nevada
$3.59K +$4.99K +13 New
ASN
12
Advisory Services Network
Georgia
$2.75K +$3.84K +10 New
IA
13
IFP Advisors
Florida
$1K – – –
NSIM
14
North Star Investment Management
Illinois
$414 – – –
WTB
15
Washington Trust Bank
Washington
– -$33K -82 Closed
Simplex Trading
16
Simplex Trading
Illinois
– -$11.5K -30 Closed

PPBT Hedge Fund Activity: Q4 2022 in Review

14 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q4 2022, worth a combined $240K — up 6.9% from $224K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new PPBT positions and 2 closed out — a net gain of 4 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $87.9K. The largest seller was Group One Trading, cutting an estimated $38.4K.

  • 14 institutional investors held Purple Biotech (PPBT) as of Q4 2022, up from 10 in Q3 2022.
  • Funds reported $240K of Purple Biotech stock for Q4 2022, up 6.9% quarter-over-quarter.
  • 6 funds opened new Purple Biotech positions in Q4 2022 and 2 closed out, a net change of +4 holders.
  • The largest Purple Biotech buyer in Q4 2022 was Citadel Advisors, an estimated $87.9K added.
  • The largest Purple Biotech seller in Q4 2022 was Group One Trading, an estimated $38.4K sold.

Based on aggregated 13F filings for Q4 2022.